{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:49:12Z","timestamp":1791132552151,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6403,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1038\/labinvest.3700285","type":"journal-article","created":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T13:56:42Z","timestamp":1114523802000},"page":"908-920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis"],"prefix":"10.1016","volume":"85","author":[{"given":"Yasushi","family":"Takii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimizu-Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumiko","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Abiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihito","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Daikoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yatsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.3700285_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0676.1994.tb00067.x","article-title":"Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology","volume":"14","author":"Lohr","year":"1994","journal-title":"Liver"},{"key":"10.1038\/labinvest.3700285_bib2","first-page":"113","article-title":"Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis","volume":"21","author":"Martinez","year":"1995","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2249.1996.00871.x","article-title":"Analysis of rearranged T cell receptor (TCR) V beta transcripts in livers of primary biliary cirrhosis: preferential V beta usage suggests antigen-driven selection","volume":"103","author":"Tsai","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700285_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2249.1996.d01-759.x","article-title":"Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)","volume":"105","author":"Shindo","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700285_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.510250402","article-title":"In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset","volume":"25","author":"Harada","year":"1997","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1023\/A:1020511002025","article-title":"Cytokine profile in the liver of primary biliary cirrhosis","volume":"19","author":"Nagano","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1038\/labinvest.3700285_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.49.4.565","article-title":"Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression","volume":"49","author":"Shackel","year":"2001","journal-title":"Gut"},{"key":"10.1038\/labinvest.3700285_bib8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","article-title":"HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases","volume":"181","author":"Shimoda","year":"1995","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.3700285_bib9","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/jhep.2000.8090","article-title":"Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis","volume":"31","author":"Shimoda","year":"2000","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.25.2.133","article-title":"Bacteriuria and primary biliary cirrhosis","volume":"25","author":"Burroughs","year":"1984","journal-title":"Gut"},{"key":"10.1038\/labinvest.3700285_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(05)80225-9","article-title":"M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria","volume":"17","author":"Butler","year":"1993","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.3700285_bib12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/jhep.2001.22653","article-title":"Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?","volume":"33","author":"Harada","year":"2001","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.20024","article-title":"Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis","volume":"39","author":"Xu","year":"2004","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/labinvest.3700285_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri1004","article-title":"Innate immune sensing and its roots: the story of endotoxin","volume":"3","author":"Beutler","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/labinvest.3700285_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.3700285_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.192.2.219","article-title":"Natural interferon alpha\/beta-producing cells link innate and adaptive immunity","volume":"192","author":"Kadowaki","year":"2000","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.3700285_bib18","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells","volume":"161","author":"Luft","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700285_bib19","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"Lovgren","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.3700285_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"10.1038\/labinvest.3700285_bib21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1038\/labinvest.3700285_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon-alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.3700285_bib23","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1084\/jem.194.12.f59","article-title":"A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus","volume":"194","author":"Ronnblom","year":"2001","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.3700285_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08916930310001602128","article-title":"Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity","volume":"36","author":"Ronnblom","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1038\/labinvest.3700285_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","article-title":"Primary biliary cirrhosis","volume":"350","author":"Neuberger","year":"1997","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700285_bib26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","article-title":"Present status of autoimmune hepatitis in Japan\u2014correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis","volume":"26","author":"Toda","year":"1997","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.3700285_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.3700285_bib28","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"10.1038\/labinvest.3700285_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/08916939608995354","article-title":"Differential involvement of Th1 and Th2 cytokines in autoimmune diseases","volume":"24","author":"Kroemer","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1038\/labinvest.3700285_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1038\/labinvest.3700285_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2007-1007189","article-title":"Cytokines in primary biliary cirrhosis","volume":"17","author":"Berg","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1038\/labinvest.3700285_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0016-5085(94)90128-7","article-title":"Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis","volume":"107","author":"Napoli","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.3700285_bib33","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1038\/labinvest.3700285_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/labinvest.3700285_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","article-title":"IRF3 mediates a TLR3\/TLR4-specific antiviral gene program","volume":"17","author":"Doyle","year":"2002","journal-title":"Immunity"},{"key":"10.1038\/labinvest.3700285_bib36","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.4049\/jimmunol.170.7.3565","article-title":"Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4","volume":"170","author":"Doyle","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700285_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4049\/jimmunol.173.2.1033","article-title":"Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages","volume":"173","author":"Punturieri","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700285_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.gene.6363791","article-title":"IFNs activate toll-like receptor gene expression in viral infections","volume":"2","author":"Miettinen","year":"2001","journal-title":"Genes Immun"},{"key":"10.1038\/labinvest.3700285_bib39","doi-asserted-by":"crossref","first-page":"21502","DOI":"10.1074\/jbc.M301476200","article-title":"Species-specific regulation of Toll-like receptor 3 genes in men and mice","volume":"278","author":"Heinz","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700285_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbrc.2003.09.159","article-title":"Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains","volume":"311","author":"Tanabe","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/labinvest.3700285_bib41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/jcp.42.10.1065","article-title":"Immunolocalization of alpha interferon in liver disease","volume":"42","author":"Sutherland","year":"1989","journal-title":"J Clin Pathol"},{"key":"10.1038\/labinvest.3700285_bib42","first-page":"230","article-title":"The distribution of immunoreactive interferon-alpha in formalin-fixed paraffin-embedded normal human foetal and infant tissues","volume":"71","author":"Khan","year":"1990","journal-title":"Immunology"},{"key":"10.1038\/labinvest.3700285_bib43","first-page":"201","article-title":"The distribution of immunoreactive interferon-alpha in normal human tissues","volume":"66","author":"Khan","year":"1989","journal-title":"Immunology"},{"key":"10.1038\/labinvest.3700285_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/hep.1840130604","article-title":"Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection","volume":"13","author":"Nouri-Aria","year":"1991","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib45","first-page":"321","article-title":"Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B","volume":"13","author":"Dienes","year":"1991","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib46","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1007\/BF02088140","article-title":"Hepatic expression of interferon-alpha in chronic hepatitis B virus infection","volume":"39","author":"Fang","year":"1994","journal-title":"Digest Dis Sci"},{"key":"10.1038\/labinvest.3700285_bib47","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/labinvest.3700135","article-title":"Interferon type I gene expression in chronic hepatitis C","volume":"84","author":"Mihm","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.3700285_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1006\/viro.1999.9983","article-title":"Impaired antiviral response in human hepatoma cells","volume":"263","author":"Keskinen","year":"1999","journal-title":"Virology"},{"key":"10.1038\/labinvest.3700285_bib49","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700285_bib50","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.170.6.3059","article-title":"The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets","volume":"170","author":"Hemmi","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.3700285_bib51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/jhep.2003.50180","article-title":"Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis","volume":"37","author":"Riordan","year":"2003","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib52","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.3700285_bib53","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Kariko","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3700285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700285","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722600801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722600801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:37:23Z","timestamp":1758397043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722600801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0023683722600801"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.3700285","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}